Abbasnezhad Mohsen, Tayyebi-Khosroshahi Hamid, Ghanbarpour Amin, Habibzadeh Afshin
Dept. of Cardiology, Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Dept. of Nephrology, Tabriz University of Medical Sciences, Tabriz, Iran.
Cardiol Res. 2012 Dec;3(6):271-276. doi: 10.4021/cr241e. Epub 2012 Nov 20.
Cardiac disease is the main cause of death in hemodialysis patients. In hemodialysis patients cardiovascular complications are great clinical challenge, and function, shape and left ventricle abnormalities are present in 70 - 80 percent of dialysis patients. Changes in heart function occur in hemodialysis period and are effective in patient's prognosis. In this study we aim to evaluate time dependant clinical and echocardiographical findings in chronic hemodialysis patients.
In a cross-sectional study, 100 adult hemodialysis patients (51% male and 49% female with mean age 52.13 ± 12.69 years) visiting dialysis unit in Imam Reza and Madani hospitals between years 2010 and 2011 were studied in group 1 (hemodialysis ≤ 6 months), group 2 (hemodialysis for 6 months to 3 years) and group 3 (hemodialysis ≥ 3 years). Demographic, laboratory and echocardiographic findings were compared between groups.
Among demographic findings, group 3 had significantly higher diastolic blood pressure and weight gain and was older than other two groups (P < 0.05). By increase in hemodialysis period, patients had higher blood urea nitrogen and lower serum albumin levels (P < 0.05). Potassium level in group 2 was significantly higher than group 3 and that was higher than group 1. There was no difference between groups in left ventricular hypertrophy (LVH), left atrium dilatation, ejection fraction and mitral insufficiency. Diastolic dysfunction increased in line with increase in hemodialysis period (P = 0.007). Hemodialysis period was higher in patients with LVH than those without (34.80 ± 9.2 months versus 18.51 ± 2.22 months, P = 0.01).
In hemodialysis patients, diastolic dysfunction increases by the hemodialysis time (years). LVH and LA dilation also increase during time, but not significantly.
心脏疾病是血液透析患者的主要死因。在血液透析患者中,心血管并发症是巨大的临床挑战,70% - 80%的透析患者存在心脏功能、形态及左心室异常。心脏功能变化发生在血液透析期间,且对患者预后有影响。在本研究中,我们旨在评估慢性血液透析患者随时间变化的临床及超声心动图表现。
在一项横断面研究中,对2010年至2011年间在伊玛目·礼萨医院和马达尼医院透析科就诊的100例成年血液透析患者进行研究,分为1组(血液透析≤6个月)、2组(血液透析6个月至3年)和3组(血液透析≥3年)。比较各组的人口统计学、实验室及超声心动图检查结果。
在人口统计学结果中,3组的舒张压、体重增加显著更高,且年龄大于其他两组(P < 0.05)。随着血液透析时间延长,患者血尿素氮升高,血清白蛋白水平降低(P < 0.05)。2组的钾水平显著高于3组,且高于1组。各组间左心室肥厚(LVH)、左心房扩大、射血分数及二尖瓣关闭不全无差异。舒张功能障碍随血液透析时间延长而增加(P = 0.007)。LVH患者的血液透析时间高于无LVH患者(34.80 ± 9.2个月对18.51 ± 2.22个月,P = 0.01)。
在血液透析患者中,舒张功能障碍随血液透析时间(年)增加。LVH和左心房扩大也随时间增加,但不显著。